RecruitingPhase 2NCT06517641

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical College of Wisconsin
Principal Investigator: Jennifer Romeril
Intervention: Haploidentical donor bone marrow transplant(drug)
Enrollment: 60 enrolled
Eligibility: 3-75 years · All sexes
Timeline: 2025 – 2028

Study locations (20)

University of Alabama at Birmingham, Birmingham, Alabama, United States
City of Hope, Duarte, California, United States
University of California, Los Angeles, Los Angeles, California, United States
Stanford University, Stanford, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Emory Winship Cancer Institute, Atlanta, Georgia, United States
Blood and Marrow Transplant Center at Northside Hospital, Atlanta, Georgia, United States
University of Kansas Medical Center, Westwood, Kansas, United States
Johns Hopkins University, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Missouri, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
+5 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06517641 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia →

← Back to all trials